EMERYVILLE, Calif., Jan. 6, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing...
Present
According to the US Bureau of Labor Statistics' February Job Openings and Labor Turnover Survey (JOLTS), there were 8.7 million...
